Phathom Pharmaceuticals (PHAT) Return on Assets: 2022-2025
Historic Return on Assets for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Sep 2025 value amounting to -1.12%.
- Phathom Pharmaceuticals' Return on Assets fell 16.00% to -1.12% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.12%, marking a year-over-year decrease of 16.00%. This contributed to the annual value of -0.84% for FY2024, which is 15.00% down from last year.
- Per Phathom Pharmaceuticals' latest filing, its Return on Assets stood at -1.12% for Q3 2025, which was up 7.71% from -1.21% recorded in Q2 2025.
- Phathom Pharmaceuticals' Return on Assets' 5-year high stood at -0.62% during Q4 2023, with a 5-year trough of -1.26% in Q1 2023.
- Over the past 3 years, Phathom Pharmaceuticals' median Return on Assets value was -0.90% (recorded in 2023), while the average stood at -0.93%.
- In the last 5 years, Phathom Pharmaceuticals' Return on Assets skyrocketed by 62bps in 2024 and then plummeted by 39bps in 2025.
- Phathom Pharmaceuticals' Return on Assets (Quarterly) stood at -1.08% in 2022, then skyrocketed by 46bps to -0.62% in 2023, then dropped by 25bps to -0.87% in 2024, then dropped by 16bps to -1.12% in 2025.
- Its last three reported values are -1.12% in Q3 2025, -1.21% for Q2 2025, and -1.03% during Q1 2025.